Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

被引：7

作者：

Milazzo, L ^{[1
]}

Rusconi, S

Testa, L

La Seta-Catamancio, S

Galazzi, M

Kurtagic, S

Citterio, P

Gianotto, M

Grassini, A

Adorni, F

d'Arminio-Monforte, A

Galli, M

Moroni, M

机构：

[1] Univ Milan, Osped Luigi Sacco, Ist Malattie Infett & Trop, Milan, Italy

[2] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 22卷 / 01期

关键词：

D O I：

10.1097/00042560-199909010-00013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：101 / 103

页数：3

相关论文

共 15 条

[11] 2-DRUG COMBINATIONS OF ZIDOVUDINE, DIDANOSINE, AND RECOMBINANT INTERFERON-ALPHA A INHIBIT REPLICATION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNERGISTICALLY INVITRO
JOHNSON, VA
MERRILL, DP
VIDELER, JA
CHOU, TC
BYINGTON, RE
ERON, JJ
DAQUILA, RT
HIRSCH, MS
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) : 646 - 655
[12] POTENTIAL MECHANISM FOR SUSTAINED ANTIRETROVIRAL EFFICACY OF AZT-3TC COMBINATION THERAPY
LARDER, BA
KEMP, SD
HARRIGAN, PR
[J]. SCIENCE, 1995, 269 (5224) : 696 - 699
[13] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
Palella, FJ
Delaney, KM
Moorman, AC
Loveless, MO
Fuhrer, J
Satten, GA
Aschman, DJ
Holmberg, SD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) : 853 - 860
[14] RUSCONI S, 1997, ANTIVIR THER, V2, P41
[15] Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment
Winters, MA
Schapiro, JM
Lawrence, J
Merigan, TC
[J]. JOURNAL OF VIROLOGY, 1998, 72 (06) : 5303 - 5306